NDC11 65162091174
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 65162-0911-74 | 65162-0911 |
| 65162-911-74 | 65162-911 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Torvex | DICLOFENAC SODIUM AND MENTHOL, METHYL SALICYLATE | Florrax Pharmaceutical | 55a35d04-d75b-4e76-972f-4710035763c9 | 2026-08-06 | Boxed warning, Warnings, Adverse reactions | 65162-911-74 65162091174 |
| Orthrexo | DICLOFENAC SODIUM AND MENTHOL, METHYL SALICYLATE | V2 Pharma, LLC | eb070904-4f6f-42c0-981d-8dc850040185 | 2026-04-02 | Boxed warning, Warnings, Adverse reactions | 65162-911-74 65162091174 |
| Orthaphen | DICLOFENAC SODIUM AND MENTHOL, METHYL SALICYLATE | V2 Pharma, LLC | 1583e691-5823-4a68-aafc-bf80b8854233 | 2025-07-28 | Boxed warning, Warnings, Adverse reactions | 65162-911-74 65162091174 |
| Fenovar | DICLOFENAC SODIUM AND MENTHOL, METHYL SALICYLATE | V2 Pharma, LLC | cca25bd7-2afd-4ff1-adb3-0a77dfcd4342 | 2024-11-01 | Boxed warning, Warnings, Adverse reactions | 65162-911-74 65162091174 |
| Diclofenac Sodium | DICLOFENAC | Amneal Pharmaceuticals LLC | 78873f83-cea9-44d4-8ad4-8cb9257e5c7f | 2024-07-16 | Boxed warning, Warnings, Adverse reactions | 65162-911-74 65162-911 65162091174 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.